With the ESS deal complete the focus will return to uplisting. What is the general opinion?
I believe AMBS should definitely wait for revenue and a steady infusion of cash before RS and uplist IMO.
WD
(0)
(0)
Amarantus Bioscience Holdings (AMBS) Stock Research Links
-
-
-
-
-
-
-
